Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations
Corey V. Dinunno
, Chelsea N. Lopez
, Luma Succar
, Duc T. Nguyen
, Edward A. Graviss
,
Eric Salazar
, Kevin R. Donahue
Department of Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Blood Clotting Factor 10a Inhibitor
100%
Antithrombotic
62%
Major Bleeding
50%
Patient
25%
Inpatient
25%
Study Design
25%
Hazard Ratio
12%
Bleeding
12%
Combination Therapy
12%
Thrombosis
12%
Anticoagulation
12%
Blood Stasis
12%
Retrospective Cohort Study
12%
Patient Population
12%
Thromboembolism
12%
Rivaroxaban
12%
Apixaban
12%
Analysis
12%
Laboratory
12%
Monitoring
12%
Patient Characteristics
12%
Ciclonicate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 10a Inhibitor
100%
Anticoagulant Agent
62%
Bleeding
12%
Thrombosis
12%
Thromboembolism
12%
Rivaroxaban
12%
Apixaban
12%
Ciclonicate
12%